Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hedy Lee Kindler

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Hematology/Oncology Clinics of North America|December 6, 2005
Antiangiogenic therapies for mesotheliomaJonathan E Dowell, Hedy Lee Kindler
Seminars in Respiratory and Critical Care Medicine|April 19, 2011
Update on malignant pleural mesotheliomaNicholas Paul Campbell, Hedy Lee Kindler
Seminars in Oncology|February 12, 2002
The role of gemcitabine in the treatment of malignant mesotheliomaHedy Lee Kindler, Jan P van Meerbeeck
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Current controversies in the stage-specific multidisciplinary management of pancreatic cancerMatthew H G Katz, Jerome Landry, Hedy Lee Kindler
American Journal of Clinical Oncology|December 9, 2008
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II ConsortiumHedy Lee Kindler, Mebea Aklilu, Sreenivasa Nattam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Malignant pleural mesotheliomaAnne S Tsao, Ignacio Wistuba, Jack A Roth, et al.
Investigational New Drugs|July 12, 2008
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancerHedy Lee Kindler, Howard A Burris, Alan B Sandler, et al.
Seminars in Oncology|February 12, 2002
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agentsAnna K Nowak, Richard A Lake, Hedy Lee Kindler, et al.
American Journal of Clinical Oncology|August 3, 2005
Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancerHedy Lee Kindler, Gregory Friberg, Linda Skoog, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 9, 2012
Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancerDavid Cella, Zeeshan Butt, Hedy Lee Kindler, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Hematology/Oncology Clinics of North America|December 6, 2005
Antiangiogenic therapies for mesotheliomaJonathan E Dowell, Hedy Lee Kindler
Seminars in Respiratory and Critical Care Medicine|April 19, 2011
Update on malignant pleural mesotheliomaNicholas Paul Campbell, Hedy Lee Kindler
Seminars in Oncology|February 12, 2002
The role of gemcitabine in the treatment of malignant mesotheliomaHedy Lee Kindler, Jan P van Meerbeeck
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Current controversies in the stage-specific multidisciplinary management of pancreatic cancerMatthew H G Katz, Jerome Landry, Hedy Lee Kindler
American Journal of Clinical Oncology|December 9, 2008
Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II ConsortiumHedy Lee Kindler, Mebea Aklilu, Sreenivasa Nattam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Malignant pleural mesotheliomaAnne S Tsao, Ignacio Wistuba, Jack A Roth, et al.
Investigational New Drugs|July 12, 2008
A phase II multicenter study of L-alanosine, a potent inhibitor of adenine biosynthesis, in patients with MTAP-deficient cancerHedy Lee Kindler, Howard A Burris, Alan B Sandler, et al.
Seminars in Oncology|February 12, 2002
New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agentsAnna K Nowak, Richard A Lake, Hedy Lee Kindler, et al.
American Journal of Clinical Oncology|August 3, 2005
Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancerHedy Lee Kindler, Gregory Friberg, Linda Skoog, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 9, 2012
Validity of the FACT Hepatobiliary (FACT-Hep) questionnaire for assessing disease-related symptoms and health-related quality of life in patients with metastatic pancreatic cancerDavid Cella, Zeeshan Butt, Hedy Lee Kindler, et al.
Pageof 3